S&P 500   4,446.87 (-0.19%)
DOW   34,945.90 (+0.43%)
QQQ   370.45 (-0.77%)
AAPL   145.34 (-1.08%)
MSFT   295.30 (-1.35%)
FB   352.36 (-0.17%)
GOOGL   2,831.52 (-0.45%)
TSLA   788.77 (+1.86%)
AMZN   3,374.95 (-1.48%)
NVDA   216.36 (-2.02%)
BABA   148.02 (+2.03%)
NIO   36.05 (+1.89%)
CGC   14.50 (+4.24%)
GE   105.74 (+1.87%)
MU   75.27 (+1.65%)
AMD   107.59 (+1.69%)
T   27.61 (+1.77%)
F   14.14 (+2.61%)
ACB   6.20 (+4.20%)
DIS   178.36 (+1.34%)
PFE   44.09 (+0.34%)
BA   225.96 (+2.06%)
BAC   43.17 (+2.44%)
S&P 500   4,446.87 (-0.19%)
DOW   34,945.90 (+0.43%)
QQQ   370.45 (-0.77%)
AAPL   145.34 (-1.08%)
MSFT   295.30 (-1.35%)
FB   352.36 (-0.17%)
GOOGL   2,831.52 (-0.45%)
TSLA   788.77 (+1.86%)
AMZN   3,374.95 (-1.48%)
NVDA   216.36 (-2.02%)
BABA   148.02 (+2.03%)
NIO   36.05 (+1.89%)
CGC   14.50 (+4.24%)
GE   105.74 (+1.87%)
MU   75.27 (+1.65%)
AMD   107.59 (+1.69%)
T   27.61 (+1.77%)
F   14.14 (+2.61%)
ACB   6.20 (+4.20%)
DIS   178.36 (+1.34%)
PFE   44.09 (+0.34%)
BA   225.96 (+2.06%)
BAC   43.17 (+2.44%)
S&P 500   4,446.87 (-0.19%)
DOW   34,945.90 (+0.43%)
QQQ   370.45 (-0.77%)
AAPL   145.34 (-1.08%)
MSFT   295.30 (-1.35%)
FB   352.36 (-0.17%)
GOOGL   2,831.52 (-0.45%)
TSLA   788.77 (+1.86%)
AMZN   3,374.95 (-1.48%)
NVDA   216.36 (-2.02%)
BABA   148.02 (+2.03%)
NIO   36.05 (+1.89%)
CGC   14.50 (+4.24%)
GE   105.74 (+1.87%)
MU   75.27 (+1.65%)
AMD   107.59 (+1.69%)
T   27.61 (+1.77%)
F   14.14 (+2.61%)
ACB   6.20 (+4.20%)
DIS   178.36 (+1.34%)
PFE   44.09 (+0.34%)
BA   225.96 (+2.06%)
BAC   43.17 (+2.44%)
S&P 500   4,446.87 (-0.19%)
DOW   34,945.90 (+0.43%)
QQQ   370.45 (-0.77%)
AAPL   145.34 (-1.08%)
MSFT   295.30 (-1.35%)
FB   352.36 (-0.17%)
GOOGL   2,831.52 (-0.45%)
TSLA   788.77 (+1.86%)
AMZN   3,374.95 (-1.48%)
NVDA   216.36 (-2.02%)
BABA   148.02 (+2.03%)
NIO   36.05 (+1.89%)
CGC   14.50 (+4.24%)
GE   105.74 (+1.87%)
MU   75.27 (+1.65%)
AMD   107.59 (+1.69%)
T   27.61 (+1.77%)
F   14.14 (+2.61%)
ACB   6.20 (+4.20%)
DIS   178.36 (+1.34%)
PFE   44.09 (+0.34%)
BA   225.96 (+2.06%)
BAC   43.17 (+2.44%)
OTCMKTS:IPSEY

Ipsen Stock Forecast, Price & News

$24.58
+0.16 (+0.63 %)
(As of 09/24/2021 03:17 PM ET)
Add
Compare
Today's Range
$24.58
$24.58
50-Day Range
$23.12
$27.46
52-Week Range
$19.35
$28.10
Volume200 shs
Average Volume3,076 shs
Market Capitalization$8.24 billion
P/E Ratio11.76
Dividend Yield0.77%
Beta1.15
30 days | 90 days | 365 days | Advanced Chart
Receive IPSEY News and Ratings via Email

Sign-up to receive the latest news and ratings for Ipsen and its competitors with MarketBeat's FREE daily newsletter.


Ipsen logo

About Ipsen

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care and Consumer Healthcare. The Specialty Care segment focuses on Oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and Rare Diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The Consumer Healthcare segment include brands such as Smecta, a naturally extracted purified clay for the symptomatic treatment of acute diarrhea; Tanakan, a standardized extract from the leaves of Ginkgo biloba for the treatment of various neurological and neuro-sens or ial disorders; Forlax, an osmotic laxative indicated for the symptomatic treatment of constipation in adults an

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.53 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Ipsen (OTCMKTS:IPSEY) Frequently Asked Questions

Is Ipsen a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ipsen in the last year. There are currently 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Ipsen stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IPSEY, but not buy additional shares or sell existing shares.
View analyst ratings for Ipsen
or view top-rated stocks.

What stocks does MarketBeat like better than Ipsen?

Wall Street analysts have given Ipsen a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Ipsen wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Ipsen?

Ipsen saw a increase in short interest during the month of August. As of August 13th, there was short interest totaling 1,700 shares, an increase of 112.5% from the July 29th total of 800 shares. Based on an average daily volume of 1,500 shares, the days-to-cover ratio is currently 1.1 days.
View Ipsen's Short Interest
.

How has Ipsen's stock been impacted by COVID-19?

Ipsen's stock was trading at $14.4150 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IPSEY shares have increased by 70.5% and is now trading at $24.58.
View which stocks have been most impacted by COVID-19
.

How often does Ipsen pay dividends? What is the dividend yield for Ipsen?

Ipsen declared a dividend on Tuesday, May 25th. Investors of record on Monday, May 31st will be given a dividend of $0.5877 per share on Wednesday, June 9th. This represents a dividend yield of 2.21%. The ex-dividend date of this dividend is Friday, May 28th.
View Ipsen's dividend history
.

Is Ipsen a good dividend stock?

Ipsen pays an annual dividend of $0.19 per share and currently has a dividend yield of 0.77%. The dividend payout ratio of Ipsen is 9.09%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Ipsen will have a dividend payout ratio of 7.82% next year. This indicates that Ipsen will be able to sustain or increase its dividend.
View Ipsen's dividend history.

Who are Ipsen's key executives?

Ipsen's management team includes the following people:
  • David G. Loew, Chief Executive Officer & Director
  • Aymeric Le Chatelier, Chief Financial Officer & Executive Vice President
  • Aidan Murphy, Executive Vice President-Technical Operations
  • Howard Mayer, Executive Vice President-Research & Development
  • Steven Hildemann, Chief Medical Officer & Executive Vice President

What is Ipsen's stock symbol?

Ipsen trades on the OTCMKTS under the ticker symbol "IPSEY."

How do I buy shares of Ipsen?

Shares of IPSEY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ipsen's stock price today?

One share of IPSEY stock can currently be purchased for approximately $24.58.

How much money does Ipsen make?

Ipsen has a market capitalization of $8.24 billion and generates $3.07 billion in revenue each year. The company earns $625.98 million in net income (profit) each year or $2.09 on an earnings per share basis.

How many employees does Ipsen have?

Ipsen employs 5,700 workers across the globe.

What is Ipsen's official website?

The official website for Ipsen is www.ipsen.com.

Where are Ipsen's headquarters?

How can I contact Ipsen?

Ipsen's mailing address is 65 quai Georges Gorse, Boulogne-Billancourt cedex I0, 92650. The company can be reached via phone at (315) 833-5000 or via email at [email protected].


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.